CHLORPHENIRAMINE
First-generation alkylamine antihistamine used for allergy relief; causes sedation via H1 blockade and anticholinergic activity.
Chlorpheniramine has been used clinically since the 1950s as an effective antihistamine for allergic rhinitis and urticaria. Its serum half-life is approximately 20 hours in adults, longer than previously reported, with wide interindividual pharmacokinetic variation influenced by age, renal function, and urinary pH. Preclinical studies in rats demonstrate dose-dependent cutaneous analgesic effects comparable to local anesthetics, suggesting potential peripheral analgesic utility. Overdose can produce severe CNS symptoms, and a case report documents rhabdomyolysis and acute kidney injury at 4000 mg ingestion. Rare hematologic adverse effects including thrombocytopenia and agranulocytosis have been reported. Evidence for off-label uses beyond allergy is limited.